As of June 14, 2025, Endonovo Therapeutics Inc (ENDV) reports a Graham Number of 0.22.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Endonovo Therapeutics Inc's Graham Number
Over recent years, Endonovo Therapeutics Inc's Graham Number has shown significant volatility. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2022-12-31 | 0.22 |
| 2021-12-31 | 0.22 |
| 2020-12-31 | 0.08 |
| 2019-12-31 | 0.60 |
| 2018-12-31 | 0.27 |
This slight upward trend highlights how Endonovo Therapeutics Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Endonovo Therapeutics Inc's Graham Number to Peers
To better understand Endonovo Therapeutics Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Endonovo Therapeutics Inc (ENDV) | 0.22 |
| Karuna Therapeutics Inc (KRTX) | 42.65 |
| Atreca Inc (BCEL) | 16.00 |
| Caladrius Biosciences Inc (CLBS) | 3.95 |
Compared to its competitors, Endonovo Therapeutics Inc's Graham Number is lower than all peers, which may indicate relative fundamental weakness by Graham's criteria.